Skip to main content
. 2021 Apr 21;9(5):444. doi: 10.3390/biomedicines9050444

Figure 8.

Figure 8

Schematic of sanguinarine antiplatelet activity. Sanguinarine attenuates collagen-induced platelet activation (including α and dense granule release) and thrombus formation by targeting the GPVI pathway (inhibiting the phosphorylation of Syk-PLCγ2 and PI3K-Akt-GSK3β), intracellular Ca2+ mobilization and integrin αIIbβ3-mediated “outside-in” signal transduction (inhibiting the phosphorylation of src). (Inhibit Inline graphic; Induce Inline graphic)